Misleading claims by Popp et al. in BMJ Journal

Rapid Response to Editor of BMJ Evidence Based Medicine

Re: Popp M, Kranke P, Meybohm P, et al. Evidence on the efficacy of ivermectin for COVID-

19: another story of apples and oranges. BMJ Evidence-Based Medicine Published Online

First: 20 August 2021. doi: 10.1136/bmjebm-2021-111791

Andrew Bryant MSc

Population Health Sciences Institute, Newcastle University

Theresa A Lawrie MBBCh PhD 

Edmund J Fordham PhDFInstP

EbMCsquared CIC

To the Editor

The integrity of our meta-analyses of trial data on Ivermectin for prevention and treatment of Covid-19 is questioned by authors of a recent Cochrane review. We agree that misleading information on Covid-19 treatment abounds in social and mainstream media as well as in journal opinion pieces. However, Bryant et al is a non-commissioned research paper that strictly followed PRISMA systematic review guidelines.

Download pdf

[dflip id=”5091″ ][/dflip]